Zacks: Analysts Anticipate Genmab A/S (NASDAQ:GMAB) Will Announce Earnings of $0.21 Per Share

Brokerages predict that Genmab A/S (NASDAQ:GMAB – Get Rating) will announce earnings of $0.21 per share for the current quarter, Zacks reports. Five analysts have issued estimates for Genmab A/S’s earnings. The lowest EPS estimate is $0.17 and the highest is $0.25. Genmab A/S posted earnings per share of $0.08 in the same quarter last […]

Related Keywords

Denmark , ,Morgan Stanley ,Jpmorgan Chase Co ,Liberty Wealth Management ,Zacks Investment Research ,Covestor Ltd ,Bessemer Group Inc ,Cordasco Financial Network ,Get Rating ,Investment Research ,Wealth Management ,Financial Network ,Captrust Financial Advisors ,Financial Advisors ,Genmaba S ,Nasdaq Gmab ,Gmab ,Medical ,Ratings ,Consensus ,